The mixture was stirred under a hydrogen atmosphere for 20 h at r.t., then 4 h at 50 C, filtered, and evaporated to dryness under vacuum at 40 C to produce cyclopeptide 13 (7.0 g) as bis-trifluoracetate salt
Zepbound (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist that is FDA-approved along with increased physical activity and a reduced-calorie diet for chronic weight management in adults with a starting body mass index (BMI) of: 30 kg/m 2 or higher (obesity) 27 kg/m 2 or higher (overweight) with at least one weight-related condition such as high cholesterol, high blood pressure (hypertension), type 2 diabetes, heart disease, or obstructive sleep apnea
Studies have shown that growth hormone plays a large role in converting adipose tissue into energy [8, 10]
Therefore, patients treated with Ozempic or Wegovy experienced significant reductions in body weight compared to a placebo
Patients with very low body fat may need to pinch the skin gently to ensure subcutaneous placement